These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38385093)

  • 21. A Scoping Review of Health Research with Racially/Ethnically Minoritized Adults with Intellectual and Developmental Disabilities.
    Williamson HJ; Chico-Jarillo TM; Sasse S; Rennie L; Etcitty JR; Howe CL; Lee MS; Armin JS
    Dev Disabil Netw J; 2023; 3(2):. PubMed ID: 37829932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
    Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes.
    Sawyer A; Sobczak M; Forlenza GP; Alonso GT
    Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of Technology in Older Adults with Type 1 Diabetes: Clinical Characteristics and Glycemic Metrics.
    Munshi M; Slyne C; Davis D; Michals A; Sifre K; Dewar R; Atakov-Castillo A; Toschi E
    Diabetes Technol Ther; 2022 Jan; 24(1):1-9. PubMed ID: 34524033
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
    Levitt DL; Spanakis EK; Ryan KA; Silver KD
    Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Awareness of Palliative Care, Hospice Care, and Advance Directives in a Racially and Ethnically Diverse Sample of California Adults.
    Bazargan M; Cobb S; Assari S; Kibe LW
    Am J Hosp Palliat Care; 2021 Jun; 38(6):601-609. PubMed ID: 33535787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2011; 11(4):1-29. PubMed ID: 23074416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Empowering Us": A community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels.
    Read M; Henshaw KN; Zaharieva DP; Brown TC; Varga AE; Bray C; Cox M; Goody-Rohdin PJ; Hider K; Jelleyman P; Jenkins A; Jones C; Kerr P; Leach R; Martin K; Oreskovic N; O'Sullivan G; Rucioch J; Sims C; Smart C; Speight J; Stanistreet J; Tippett M; Tivalu I; Withers T; O'Neal DN
    Diabetes Res Clin Pract; 2023 Aug; 202():110830. PubMed ID: 37451626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial and ethnic differences in uncontrolled diabetes mellitus among adults taking antidiabetic medication.
    Berg KA; Bharmal N; Tereshchenko LG; Le P; Payne JY; Misra-Hebert AD; Rothberg MB
    Prim Care Diabetes; 2024 Jun; 18(3):368-373. PubMed ID: 38423828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018.
    Li P; Zhang P; Guan D; Guo J; Zhang Y; Pavkov ME; Bullard KM; Shao H
    Diabetes Obes Metab; 2023 Feb; 25(2):516-525. PubMed ID: 36251173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Racial/Ethnic Disparities in Continuous Glucose Monitor Use in Pediatric Type 1 Diabetes.
    Lai CW; Lipman TH; Willi SM; Hawkes CP
    Diabetes Technol Ther; 2021 Nov; 23(11):763-767. PubMed ID: 34143673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes.
    Baboun D; Solano N; Del Toro V; Alvarez-Salvat R; Granados A; Carrillo-Iregui A
    J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1128-1132. PubMed ID: 37852007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial and Ethnic Inequities in Cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
    Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
    JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis.
    Conway RB; Gerard Gonzalez A; Shah VN; Geno Rasmussen C; Akturk HK; Pyle L; Forlenza G; Alonso GT; Snell-Bergeon J
    Diabetes Metab Syndr Obes; 2023; 16():2295-2310. PubMed ID: 37551339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health Care Disparities in Use of Continuous Glucose Monitoring.
    Isaacs D; Bellini NJ; Biba U; Cai A; Close KL
    Diabetes Technol Ther; 2021 Sep; 23(S3):S81-S87. PubMed ID: 34546086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring.
    Telo GH; Volkening LK; Butler DA; Laffel LM
    Diabetes Technol Ther; 2015 Jun; 17(6):373-8. PubMed ID: 25749206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.